AbbVie says it hasn't called off the deal, but its board needs to weigh whether it is still a good idea in light of new tax regulations announced by the U.S. Treasury in September.
Business Heds Index, Seattle Post-Intelligencer: Business
Tue, 10/14/2014 - 6:32pm
AbbVie says it hasn't called off the deal, but its board needs to weigh whether it is still a good idea in light of new tax regulations announced by the U.S. Treasury in September.